A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...

(L to R) Justin Mattice, SVP and general manager at Envo, moderates a panel at Reuters Pharma USA with Kyowa Kirin's Debra Jennings, EVERSANA's Faruk Abdullah, Gilead Science's Pranay Butala, and ...

The World Economic Forum ‘Future of Jobs Report’ 2018 has identified negotiation as a skill which will increase in importance over the next five years as workplaces continue to change and evolve.

Applications for the 2025/2026 academic year are no longer being accepted. Successful candidates will be contacted by NorQuest College. The next intake period will begin in the summer of 2026. The ...

Program applications are currently closed. Check back for the 2026-27 program intake, opening in spring 2026. sustain healthy fish and wildlife populations conserve ecological services that benefit ...

The Priests are taking this week's Morning Service and sing the Lords Prayer together.